<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82305">
  <stage>Registered</stage>
  <submitdate>27/09/2007</submitdate>
  <approvaldate>5/10/2007</approvaldate>
  <actrnumber>ACTRN12607000508471</actrnumber>
  <trial_identification>
    <studytitle>Laser Therapy in The Management of Achilles Tendon Injury</studytitle>
    <scientifictitle>Low Level Laser Therapy versus placebo in the management of Achilles tendinopathy using the VISA-A scale as a measure of function.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Achilles Tendinopathy</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Eccentric exercise, low level laser therapy
Eccentric exercise; twice daily for 12 weeks.
Laser therapy; 810nm, 100mW, 3J to 6 points around the tendon, 3 times per week for 4 weeks.</interventions>
    <comparator>The control group will recieve eccentric exercise; twice daily for 12 weeks, and placebo laser therapy 3 times per week for the first 4 weeks.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Victorian Institute of Sports Assessment - Achilles (VISA-A) functional questionnaire</outcome>
      <timepoint>baseline, 4 weeks, 12 weeks &amp; 52 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Pain measured on a Visual Analogue Scale(VAS)</outcome>
      <timepoint>baseline, 4 weeks, 12 weeks &amp; 52 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Diagnosis of Achilles tendinopathy and not had any treatment on the Achilles tendon in the previous 3 months</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Contraindications to Low Level Laser Therapy.
Non-steroidal Anti-inflammatory Drug (NSAID) use.
Insertional Tendinopathy.
Bursitis.
Neurological signs.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Subjects will be recruited through advertisements in the local press and from local physiotherapy or GP practices.  The principal investigator will assess subjects against inclusion/exclusion criteria and subjects meeting the criteria will be passed on to the clinic receptionist.  Concealed allocation will be carried out by the receptionist who asks the patient to draw from 40 sealed opaque envelopes and arranges an appointment with the treating therapist.</concealment>
    <sequence>A computer generated list will be used to randomize subjects meeting the inclusion criteria into one of two groups, Laser or Placebo.  The clinic administrator will be responsible for randomisation, after the subject has given informed consent.  The laser equipment is to be fitted with a switch marked “1” or “2” to indicate placebo or active laser; only the principal investigator will know which position is active.  The treating physiotherapist will only be aware that 40 subjects are to receive LLLT at 3J per point, with the laser switched to “1” or “2” as per the treatment sheet.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>15/10/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Otago</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Steve Tumilty</primarysponsorname>
    <primarysponsoraddress>School of Physiotherapy,
325 Great King Street,
Dunedin</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Otago</fundingname>
      <fundingaddress>P.O. Box 54
Dunedin</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>G.D. Baxter</othercollaboratorname>
      <othercollaboratoraddress>School of Physiotherapy,
325 Great King Street,
Dunedin</othercollaboratoraddress>
      <othercollaboratorcountry>New Zealand</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>J.H.Abbott</othercollaboratorname>
      <othercollaboratoraddress>School of Physiotherapy,
325 Great King Street,
Dunedin</othercollaboratoraddress>
      <othercollaboratorcountry>New Zealand</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>D.Hurley</othercollaboratorname>
      <othercollaboratoraddress>University College Dublin,
Belfield.
Dublin</othercollaboratoraddress>
      <othercollaboratorcountry>Ireland</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>S McDonough</othercollaboratorname>
      <othercollaboratoraddress>University of Ulster
Newtownabbey
Co Antrim
Northern Ireland</othercollaboratoraddress>
      <othercollaboratorcountry>United Kingdom</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>J Munn</othercollaboratorname>
      <othercollaboratoraddress>School of Physiotherapy,
325 Great King Street,
Dunedin</othercollaboratoraddress>
      <othercollaboratorcountry>New Zealand</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>J Basford</othercollaboratorname>
      <othercollaboratoraddress>Mayo Clinic
Rochester
Minnesota</othercollaboratoraddress>
      <othercollaboratorcountry>United States of America</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>L Laakso</othercollaboratorname>
      <othercollaboratoraddress>Griffith University, Queensland, Australia</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary aim of this study is to get an idea of whether Low-Level Laser Therapy (LLLT) may be effective in the management of Achilles Tendinopathy, and give benefit to the patients over and above that of eccentric exercises alone. The  Hypothesis is that the treatment group will have less pain and more improvement in functional outcome measures score compared to the control group.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Lower South Regional Ethics Committee</ethicname>
      <ethicaddress>Ministry of Health,
229 Moray Place,
Dunedin</ethicaddress>
      <ethicapprovaldate>25/09/2007</ethicapprovaldate>
      <hrec>LRS/07/08/032</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Steve Tumilty</name>
      <address>School of Physiotherapy,
325 Great King Street,
Dunedin</address>
      <phone>+64-3-479-4034</phone>
      <fax>+64-3-479-8414</fax>
      <email>steve.tumilty@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Steve Tumilty</name>
      <address>School of Physiotherapy,
325 Great King Street,
Dunedin</address>
      <phone>+64-3-479-4034</phone>
      <fax>+64-3-479-8414</fax>
      <email>steve.tumilty@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>